Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yongjun Koh"'
Autor:
Seongryong Kim, Galam Leem, Junjeong Choi, Yongjun Koh, Suho Lee, Sang-Hee Nam, Jin Su Kim, Chan Hee Park, Ho Kyoung Hwang, Kyoung Il Min, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Eui-Cheol Shin, Chang Moo Kang, Seungmin Bang, Jong-Eun Park
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-18 (2024)
Abstract Background Recent studies using single-cell transcriptomic analysis have reported several distinct clusters of neoplastic epithelial cells and cancer-associated fibroblasts in the pancreatic cancer tumor microenvironment. However, their mole
Externí odkaz:
https://doaj.org/article/1c44fc99a70f419f9ea61b463f3a7c7e
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with fatal pulmonary fibrosis. Small interfering RNAs (siRNAs) can be developed to induce RNA interference against SAR
Externí odkaz:
https://doaj.org/article/ea356f057fde485a94f3bae30e8104fd
Autor:
Dongil Park, Dahye Lee, Yoonjoo Kim, Yeonhee Park, Yeon-Jae Lee, Jeong Eun Lee, Min-Kyung Yeo, Min-Woong Kang, Yooyoung Chong, Sung Joon Han, Jinwook Choi, Jong-Eun Park, Yongjun Koh, Jaehyeok Lee, YongKeun Park, Ryul Kim, Jeong Seok Lee, Jimin Choi, Sang-Hyun Lee, Bosung Ku, Da Hyun Kang, Chaeuk Chung
Publikováno v:
Cells, Vol 12, Iss 14, p 1854 (2023)
One major challenge associated with lung cancer organoids (LCOs) is their predominant derivation from surgical specimens of patients with early-stage lung cancer. However, patients with advanced lung cancer, who are in need of chemotherapy, often can
Externí odkaz:
https://doaj.org/article/29851c3eaa914ca6810b4b1723a5cb8a
Autor:
Dowoon Gu, Seung Hyun Ahn, Sangkyeong Eom, Hye-Sook Lee, Juyoung Ham, Dong Ha Lee, You Kyung Cho, Yongjun Koh, Elizaveta Ignatova, Eun-Sook Jang, Sung Wook Chi
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 23, Iss , Pp 1172-1190 (2021)
Small interfering RNAs (siRNAs) therapeutically induce RNA interference (RNAi) of disease-causing genes, but they also silence hundreds of seed-matched off-targets as behaving similar to microRNAs (miRNAs). miRNAs control the pathophysiology of tumor
Externí odkaz:
https://doaj.org/article/7fd98d38d1e74d2cbef1a81a63208ab9
Autor:
Guo Nan Yin, Do-Kyun Kim, Ji In Kang, Yebin Im, Dong Sun Lee, Ah-reum Han, Jiyeon Ock, Min-Ji Choi, Mi-Hye Kwon, Anita Limanjaya, Saet-Byel Jung, Jimin Yang, Kwang Wook Min, Jeongwon Yun, Yongjun Koh, Jong-Eun Park, Daehee Hwang, Jun-Kyu Suh, Ji-Kan Ryu, Ho Min Kim
Publikováno v:
Experimental & Molecular Medicine. 54:626-638
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by inappropriate hyperglycemia, which causes endothelial dysfunction and peripheral neuropathy, ultimately leading to multiple complications. One prevalent complication is diabetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2fe977d655aecb6896c03bbaff9cdd
https://doi.org/10.1038/s12276-022-00773-5
https://doi.org/10.1038/s12276-022-00773-5
Autor:
Bumsoo Kim, Yongjun Koh, Hyunsu Do, Younghee Ju, Jong Bin Choi, Gahyang Cho, Han-Wook Yoo, Beom Hee Lee, Jinju Han, Jong-Eun Park, Yong-Mahn Han
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 13861
Noonan syndrome (NS) is a genetic disorder mainly caused by gain-of-function mutations in Src homology region 2-containing protein tyrosine phosphatase 2 (SHP2). Although diverse neurological manifestations are commonly diagnosed in NS patients, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84ad440fd3baae53a1440cb9c431d4d2
https://doi.org/10.3390/ijms232213861
https://doi.org/10.3390/ijms232213861
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with fatal pulmonary fibrosis. Small interfering RNAs (siRNAs) can be developed to induce RNA interference against SARS-CoV-2,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf79725c75e030436908591882de05b3
https://pubmed.ncbi.nlm.nih.gov/34580386
https://pubmed.ncbi.nlm.nih.gov/34580386
Autor:
Sung Wook Chi, Eun Sook Jang, Sangkyeong Eom, You Kyung Cho, Juyoung Ham, Hye Sook Lee, Dowoon Gu, Dong Ha Lee, Yongjun Koh, Elizaveta Ignatova, Seung Hyun Ahn
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 23, Iss, Pp 1172-1190 (2021)
Molecular Therapy: Nucleic Acids, Vol 23, Iss, Pp 1172-1190 (2021)
Small interfering RNAs (siRNAs) therapeutically induce RNA interference (RNAi) of disease-causing genes, but they also silence hundreds of seed-matched off-targets as behaving similar to microRNAs (miRNAs). miRNAs control the pathophysiology of tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b0a9639734fd84e0bfd996cb15e531
https://pubmed.ncbi.nlm.nih.gov/33664996
https://pubmed.ncbi.nlm.nih.gov/33664996